Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.03
-0.40 (-4.74%)
At close: Oct 22, 2026, 4:00 PM EDT
8.19
+0.16 (1.99%)
After-hours: Oct 22, 2026, 7:30 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $52.84 million as of October 22, 2026. It is the 29,724th most valuable company in the world and the 4,577th biggest in the United States. Its market cap has increased by 34.96% in one year.
Market Cap
52.84M
Enterprise Value
-76.90M
1-Year Change
34.96%
Global Rank
Country Rank
#4,577 United States
Category
ChartMarket Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $52.84M, a decrease of -87.62%. That is a compound annual growth rate of -34.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 52.84M | 57.21% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 58.60M |
| OS Therapies | 58.22M |
| Pliant Therapeutics | 56.50M |
| Caribou Biosciences | 55.64M |
| Boundless Bio | 55.27M |
| Connect Biopharma Holdings | 55.12M |
| Alps Group | 54.91M |
| RenovoRx | 54.16M |